Silver Book Fact

Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money

Fact image

Pietzsch J, Garner A, Marks W. Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States. Neuromodulation. 2016; 19(7). https://onlinelibrary.wiley.com/doi/abs/10.1111/ner.12474

Reference

Title
Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States
Publication
Neuromodulation
Publication Date
2016
Authors
Pietzsch J, Garner A, Marks W
Volume & Issue
Volume 19, Issue 7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • Medicaid Costs, 5-Year Delayed Onset  
  • It is imperative to weigh costs of implementing new technologies for predicting onset of Alzheimer’s disease through biomarkers and delaying onset earlier against the potential benefits of improving health. Overall…  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • Spinal Cord Stimulation Shows Improvements for Parkinson’s Patients
     
  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease in 2050 by…